Another study revealed that combined treatment of curcumin with epigallocatechin gallate reduced the CSCs population in breast cancer cells via inhibiting STAT3 phosphorylation, retaining STAT3-NF-κB interaction and inducing apoptosis in CSCs [117]. The gene discussed is STAT3; the disease is breast carcinoma.